Sodium-dependent noradrenaline transporter — Drug Target
All drugs that target Sodium-dependent noradrenaline transporter — marketed and clinical-stage. Includes 13 drug classes acting on this target.
Drug classes
Central Nervous System Stimulant [EPC] · Amphetamine Anorectic · Benzothiazole [EPC] · mazindol · reboxetine · phenmetrazine · Indirectly Acting Sympathomimetic Amines · Tricyclic Antidepressant · Norepinephrine Reuptake Inhibitor · Tricyclic Antidepressants · betanidine · ipriflavone
Marketed (12)
- Xelstrym · UCB · Central Nervous System Stimulant [EPC] · Nephrology
Xelstrym works by blocking the reuptake of noradrenaline, allowing it to stay in the brain for longer and increasing alertness and focus. - Desoxyn · Ajenat Pharms · Amphetamine Anorectic · Metabolic
Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity. - Rilutek · Covis · Benzothiazole [EPC] · Neuroscience
- Sanorex · mazindol · Metabolic
- Edronax · reboxetine · Neuroscience
- Fenmetrazina · Boehringer Ingelheim · phenmetrazine · Metabolic
- Propadrine · Alpharma Us Pharms · Indirectly Acting Sympathomimetic Amines · Metabolic
- Aventyl · Tricyclic Antidepressant · Neuroscience
- Strattera · Eli Lilly · Norepinephrine Reuptake Inhibitor · Neuroscience
Strattera works by blocking the reabsorption of norepinephrine in the brain, allowing more of this neurotransmitter to be available for use. - Lopramine · Tricyclic Antidepressants · Neuroscience
- Esbatal · betanidine · Neuroscience
- Aventyl · Tricyclic Antidepressant · Neuroscience
Phase 2 pipeline (1)
- Osten · ipriflavone · Metabolic
Osten works by inhibiting the sodium-dependent noradrenaline transporter, which helps to regulate bone metabolism.